Stock Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Stock Screener
Compare Stocks
Penny Stock Screener
Top Product Insights Stocks
Daily Updates
Daily Analyst Ratings
Trending Stocks
Top Stock Gainers
Top Stock Losers
Most Active Stocks
Dividend Stocks
ChatGPT Stocks
New
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Market Holidays
Stock Ideas
ETF Research Tools
ETF Center
ETF Screener
Top ETFs by Smart Score
New
Compare ETFs
Top ETFs by AUM
ETFs On the Move
Top ETF Gainers
Top ETF Losers
Most Active ETFs
ETF Ideas
S&P 500 Index ETFs
Nasdaq 100 Index ETFs
S&P 500 Sector ETFs
Bond ETFs
Commodity ETFs
Currency ETFs
Industry ETFs
ETFs
Best Dividend Stocks
Best High Yield Dividend Stocks
Dividend Aristocrats
New
Dividend Stock Comparison
Dividend Calculator
Popular
Dividend Returns Comparison
Dividend Calendar
Dividends
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Experts
My Portfolio
My Watchlist
My Performance
My Portfolio Analysis
Crowd Insights
Portfolio
Stock Market News
Stock Analysis & Ideas
Popular
ETF News
Global Markets News
Expert Spotlight
TipRanks Labs
Earnings Reports Insights
Market Breakdowns
Dividend Stock News
Crypto News
News
Education
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
TipRanks Community
Careers
Contact Us
Working with TipRanks
Enterprise Solutions
Best Online Brokers
Become an Affiliate
Follow Us
More...
Plans
News
Smart Portfolio
Expert Center
Ideas
TOOLS
My Portfolio
My Watchlist
Earnings Calendar
Stock Screener
Penny Stocks
Top Stocks
ETF Center
STOCKS
BABA
AAPL
SPY
AMZN
QQQ
TSLA
NVDA
ADVANCED RESEARCH
TipRanks Premium
Invest Like a Pro with Unique Data & Simplifed Tools
Try Now
Stock Ideas
Stock Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Stock Screener
Compare Stocks
Penny Stock Screener
Top Product Insights Stocks
Options Profit Calculator
New
Daily Updates
Daily Analyst Ratings
Trending Stocks
Top Stock Gainers
Top Stock Losers
Most Active Stocks
Dividend Stocks
ChatGPT Stocks
New
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Market Holidays
ETFs
ETF Research Tools
ETF Center
ETF Screener
New
Top ETFs by Smart Score
New
Compare ETFs
Top ETFs by AUM
ETFs On the Move
Top ETF Gainers
Top ETF Losers
Most Active ETFs
ETF Ideas
S&P 500 Index ETFs
Nasdaq 100 Index ETFs
S&P 500 Sector ETFs
Bond ETFs
Commodity ETFs
Currency ETFs
Industry ETFs
Dividends
Best Dividend Stocks
Best High Yield Dividend Stocks
Dividend Aristocrats
New
Dividend Stock Comparison
Dividend Calculator
Popular
Dividend Returns Comparison
Dividend Calendar
Crypto
Crypto Center
Bitcoin
Ethereum
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Portfolio
My Portfolio
My Watchlist
My Performance
My Portfolio Analysis
Crowd Insights
News
Stock Market News
Stock Analysis & Ideas
Popular
ETF News
Global Markets News
Expert Spotlight
TipRanks Labs
Earnings Reports Insights
Market Breakdowns
Dividend Stock News
Crypto News
More
Education
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
TipRanks Community
Careers
Contact Us
Working with TipRanks
Enterprise Solutions
Best Online Brokers
Become an Affiliate
Follow Us
Plans & Pricing
ACER
Stock Latest News
Press Releases
Acer Therapeutics Reports Q1 2023 Financial Results and Provides Corporate Update
25d ago
ACER
Press Releases
Acer Therapeutics Announces OLPRUVA™ Commercial Launch Progressing Ahead of Schedule
1M ago
ACER
The Fly
Acer Therapeutics announces update on OLPRUVA commercial launch
1M ago
ACER
The Fly
Acer Therapeutics reports Q4 EPS (54c), consensus (37c)
2M ago
ACER
Press Releases
Acer Therapeutics Reports Q4 and Full Year 2022 Financial Results and Provides Corporate Update
2M ago
ACER
The Fly
Biotech Alert: Searches spiking for these stocks today
3M ago
ACER
CNTB
The Fly
Acer Therapeutics: Data presented at SIMD on Urea Cycle Disorders
3M ago
ACER
Press Releases
Acer Therapeutics Announces Data Presented at Society for Inherited Metabolic Disorders Annual Meeting Identifying Preferred Urea Cycle Disorder Treatment Attributes
3M ago
ACER
The Fly
Acer Therapeutics prices $2.68M registered direct offering
3M ago
ACER
Press Releases
Acer Therapeutics Announces $2.675 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
3M ago
ACER
The Fly
Biotech Alert: Searches spiking for these stocks today
3M ago
ACER
CBAY
Market News
Acer Therapeutics Plummets on Pausing ACER-801 Trial
3M ago
ACER
The Fly
Acer reports Phase 2 trial of ACER-801 did not achieve statistical significance
3M ago
ACER
Press Releases
Acer Therapeutics Announces Topline Results from ACER-801 (Osanetant) Phase 2a Trial
3M ago
ACER
The Fly
Acer Therapeutics announces presentation at upcoming meeting for SIMD
3M ago
ACER
Press Releases
Acer Therapeutics Announces Full Enrollment of Phase 2a Trial of ACER-801 (Osanetant) for Treatment of Moderate to Severe Vasomotor Symptoms Associated with Menopause
4M ago
ACER
The Fly
Acer Therapeutics announces full enrollment in Phase 2a trial of ACER-801
4M ago
ACER
The Fly
Acer Therapeutics announces corporate update, anticipated milestones
5M ago
ACER
Press Releases
Acer Therapeutics Highlights Key 2022 Achievements and Pipeline Advancements, and Provides Anticipated 2023 Milestones
5M ago
ACER
The Fly
Acer Therapeutics announces initiation of two trials of ACER-801
5M ago
ACER
Press Releases
Acer Therapeutics Announces Initiation of Two Investigator-Sponsored Trials of ACER-801 (Osanetant) in Men with Adenocarcinoma of the Prostate
5M ago
ACER
The Fly
Acer Therapeutics regains compliance with Nasdaq listing rules
5M ago
ACER
Show More
You need to enable JavaScript to run this app.
